Abstract

Recently, the American Academy of Neurology released its guidelines for the diagnosis and treatment of neurologic Lyme disease. Although these guidelines were touted as “independent corroboration” of the controversial Infectious Diseases Society of America Lyme guidelines, the committees that formulated the two guidelines featured overlapping panel members (including the committee chairs) who failed to acknowledge the conflicting standards of care for patients infected with Lyme disease. The ethical obligation of a medical society to produce fair and accurate practice guidelines is discussed.